Clostridium difficile-associated diarrhea in a pediatric hospital

被引:9
|
作者
Spivack, JG
Eppes, SC
Klein, JD
机构
[1] Alfred I DuPont Hosp Children, Div Infect Dis, Nemours Childrens Clin Wilmington, Wilmington, DE 19899 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
关键词
D O I
10.1177/000992280304200407
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This retrospective cohort analysis examined the risk factors, symptoms, and severity of disease associated with C. difficile in pediatric inpatients. Risk factors for a C. difficile-positive test were an oncologic diagnosis, diarrhea of more than 2 days' duration, and gastrointestinal symptoms, especially abdominal pain. Over a 3.5-year period, there was a total of 22 C. difficile-positive patients, and most had mild, self-limiting diarrheal illness. No cases of C. difficile diarrhea were identified. Seventy-eight percent of the C. difficile-positive patients were found to have alternate risk factors for diarrhea. Our data indicate that C. difficile rarely causes severe diarrhea in pediatric inpatients and that C. difficile-positive testing should be limited to patients with severe prolonged diarrhea and abdominal pain.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 50 条
  • [21] Clostridium difficile-associated diarrhea in dialysis patients
    Oh, Sook Eui
    Lee, Seung Min
    Lee, Young-Ki
    Choi, Sun Ryoung
    Choi, Myung-Jin
    Kim, Jwa-Kyung
    Song, Young Rim
    Kim, Soo Jin
    Park, Tae Jin
    Kim, Sung Gyun
    Oh, Jieun
    Suh, Jang Won
    Yoon, Jong -Woo
    Koo, Ja-Ryong
    Kim, Hyung Jik
    Noh, Jung Woo
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (01) : 27 - 31
  • [22] Fluoroquinolone use and Clostridium difficile-associated diarrhea
    McCusker, ME
    Harris, AD
    Perencevich, E
    Roghmann, MC
    [J]. EMERGING INFECTIOUS DISEASES, 2003, 9 (06) : 730 - 733
  • [23] Clostridium difficile-Associated Diarrhea in the Oncology Patient
    Neemann, Kari
    Freifeld, Alison
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 25 - +
  • [24] Bezlotoxumab for the treatment of Clostridium difficile-associated diarrhea
    Thakare, R.
    Dasgupta, A.
    Chopra, S.
    [J]. DRUGS OF TODAY, 2017, 53 (07) : 385 - 392
  • [25] Diagnosis of Clostridium difficile-associated diarrhea and odor
    Wilcox, Mark H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 1110 - 1110
  • [26] Management of Severe Clostridium difficile-Associated Diarrhea
    Michael J. Krier
    George Triadafilopoulos
    [J]. Digestive Diseases and Sciences, 2009, 54 : 1199 - 1202
  • [27] Clostridium difficile-associated diarrhea in infants and children
    Vuletic, Biljana
    Ristanovic, Elizabeta
    Markovic, Slavica
    Raskovic, Zorica
    Radlovic, Vladimir
    Igrutinovic, Zoran
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2017, 145 (1-2) : 85 - 88
  • [28] Ultrasound diagnosis of Clostridium difficile-associated diarrhea
    Wiener-Well, Y.
    Kaloti, S.
    Hadas-Halpern, I.
    Munter, G.
    Yinnon, A. M.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (10) : 1975 - 1978
  • [29] Surgical patients with Clostridium difficile-associated diarrhea
    Pugliese, G
    Favero, MS
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (08): : 560 - 560
  • [30] Management and prevention of Clostridium difficile-associated diarrhea
    William P. Ciesla
    David A. Bobak
    [J]. Current Infectious Disease Reports, 2001, 3 (2) : 109 - 115